Consensus Cloud Solutions, Inc. reports news around its secure information-delivery SaaS business, including cloud fax, interoperability, data extraction and digital signature solutions. Company updates often reference the eFax brand, eFax Corporate and jSign, with emphasis on healthcare workflows that convert unstructured faxes, scans, PDFs and handwritten documents into structured data for automation and AI-enabled processing.
Financial releases cover revenue trends in the Corporate and small office/home office channels, earnings guidance, cash flow, debt management and common-stock repurchases. Other recurring items include healthcare technology conference demonstrations, security and compliance certifications such as HITRUST r2 status, and enterprise data-exchange use cases across healthcare and other regulated industries.
Ziff Davis reported Q3 2021 financial results, achieving a record revenue of $444.3 million, up 24.5% from $357.0 million in Q3 2020. Pro-forma revenues increased by 27.7%. Operating cash flow rose to $140.2 million from $114.4 million. However, GAAP earnings per diluted share dropped to $0.88 from $1.31, largely due to a $19.2 million loss on the B2B Backup business sale. Adjusted non-GAAP earnings per share increased to $2.34, a 15.8% rise. Ziff Davis reaffirmed its FY 2021 guidance, estimating revenue between $1,375-$1,389 million.
Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) has evolved from a secure digital document transmission service to a leader in digital cloud fax technology. As of October 8, 2021, it operates independently, focusing on compliance and data-driven organizations across healthcare, financial, manufacturing, and legal sectors. The company enhances documents using Natural Language Processing and Artificial Intelligence, enabling meaningful data extraction. Key features include real-time notifications, secure messaging, and universal APIs.
Consensus Cloud Solutions has successfully separated from Ziff Davis, marking its debut as an independent entity. The new company commenced trading on Nasdaq under the ticker symbol CCSI on October 7, 2021, following a special dividend distribution that allocated 80.1% of its shares to Ziff Davis stockholders. CEO Scott Turicchi expressed optimism about the company's potential in secure data exchange solutions for healthcare. The spin-off is a pivotal move, aiming to provide long-term growth and value to shareholders.